CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 53 filers reported holding CYTEIR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,920,916 | -79.8% | 676,379 | -81.5% | 0.14% | -80.7% |
| Q2 2023 | $9,522,854 | -91.6% | 3,662,636 | -7.0% | 0.74% | -90.1% |
| Q1 2023 | $112,892,832 | +1636.4% | 3,940,413 | 0.0% | 7.45% | +1734.7% |
| Q4 2022 | $6,501,681 | -14.1% | 3,940,413 | 0.0% | 0.41% | +12.5% |
| Q3 2022 | $7,566,000 | -47.7% | 3,940,413 | -18.6% | 0.36% | -49.4% |
| Q2 2022 | $14,473,000 | -20.7% | 4,840,413 | 0.0% | 0.71% | -26.0% |
| Q1 2022 | $18,248,000 | -66.8% | 4,840,413 | 0.0% | 0.96% | -63.0% |
| Q4 2021 | $55,035,000 | -35.2% | 4,840,413 | 0.0% | 2.61% | -40.7% |
| Q3 2021 | $84,949,000 | -18.0% | 4,840,413 | 0.0% | 4.39% | -4.4% |
| Q2 2021 | $103,585,000 | – | 4,840,413 | – | 4.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 4,840,413 | $84,949,000 | 4.39% |
| ACUTA CAPITAL PARTNERS, LLC | 391,974 | $6,879,000 | 2.43% |
| Ally Bridge Group (NY) LLC | 319,538 | $5,608,000 | 1.65% |
| RA Capital Management | 3,350,506 | $58,801,000 | 0.82% |
| Avidity Partners Management LP | 1,683,441 | $29,544,000 | 0.66% |
| Sofinnova Investments, Inc. | 246,321 | $4,323,000 | 0.26% |
| CAAS CAPITAL MANAGEMENT LP | 579,746 | $10,175,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 135,145 | $2,372,000 | 0.20% |
| ACT CAPITAL MANAGEMENT, LLC | 15,000 | $263,000 | 0.14% |
| Baker Brothers Advisors | 812,640 | $14,262,000 | 0.06% |